Literature DB >> 543011

In vitro and in vivo selection of two Lewis lung carcinoma cell lines.

A Sacchi, A Corsi, M Caputo, G Zupi.   

Abstract

Two tumor cell lines adapted to grow in vitro were originated from an explant of lung metastases of Lewis lung carcinoma. These lines differ in their malignancy when reinoculated into syngeneic animals; nevertheless, they do not show any difference for their in vitro clonogenic ability. From these lines 2 in vivo sublines of 3LL carcinoma were developed. The TD50 of the 2 in vivo sublines are different, and both the values obtained are lower than that of the original line. These results are interpreted as a selection of more malignant tumor cell lines.

Entities:  

Mesh:

Year:  1979        PMID: 543011     DOI: 10.1177/030089167906500601

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  7 in total

1.  Stimulation of tumor cell growth in vitro by a monoclonal antibody to a tumor specific protein (TSP-180) present on the cell surface of 3LL cells.

Authors:  A Sacchi; G Piaggio; M A Rizzo; R Falcioni; S J Kennel
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

2.  Antimetastatic action of orally administered lysozyme in mice bearing Lewis lung carcinoma.

Authors:  G Sava; L Perissin; S Zorzet
Journal:  Clin Exp Metastasis       Date:  1988 May-Jun       Impact factor: 5.150

3.  Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry.

Authors:  T Giraldi; G Sava; R Cherubino; G Bottiroli; G Mazzini
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

4.  Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.

Authors:  G Sava; S Zorzet; L Perissin; S Pacor; L Lassiani; C Nisi; A Varnavas
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  Changes of phenotypic characteristics of variants derived from Lewis lung carcinoma during long-term in vitro growth.

Authors:  A Sacchi; F Mauro; G Zupi
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

6.  Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma.

Authors:  V Grill; F Mallardi; S Zorzet; L Perissin; T Giraldi
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

7.  Effects of prolonged treatment with decarbazine on tumor metastatic potential in mice bearing Lewis lung carcinoma.

Authors:  S Zorzet; L Perissin; V Rapozzi; S Pacor; T Giraldi
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.